Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy
Dahlgren, C. V.
de Marzi, L.
Jensen, M. F.
Mackay, Ranald I
van der Tol, P.
AffiliationOncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany
MetadataShow full item record
AbstractPurpose: Experimental assessment of inter-centre variation and absolute accuracy of stopping-power-ratio (SPR) prediction within 17 particle therapy centres of the European Particle Therapy Network. Material and methods: A head and body phantom with seventeen tissue-equivalent materials were scanned consecutively at the participating centres using their individual clinical CT scan protocol and translated into SPR with their in-house CT-number-to-SPR conversion. Inter-centre variation and absolute accuracy in SPR prediction were quantified for three tissue groups: lung, soft tissues and bones. The integral effect on range prediction for typical clinical beams traversing different tissues was determined for representative beam paths for the treatment of primary brain tumours as well as lung and prostate cancer. Results: An inter-centre variation in SPR prediction (2σ) of 8.7%, 6.3% and 1.5% relative to water was determined for bone, lung and soft-tissue surrogates in the head setup, respectively. Slightly smaller variations were observed in the body phantom (6.2%, 3.1%, 1.3%). This translated into inter-centre variation of integral range prediction (2σ) of 2.9%, 2.6% and 1.3% for typical beam paths of prostate-, lung- and primary brain-tumour treatments, respectively. The absolute error in range exceeded 2% in every fourth participating centre. The consideration of beam hardening and the execution of an independent HLUT validation had a positive effect, on average. Conclusion: The large inter-centre variations in SPR and range prediction justify the currently clinically used margins accounting for range uncertainty, which are of the same magnitude as the inter-centre variation. This study underlines the necessity of higher standardisation in CT-number-to-SPR conversion.
CitationPeters N, Wohlfahrt P, Dahlgren CV, de Marzi L, Ellerbrock M, Fracchiolla F, et al. Experimental assessment of inter-centre variation in stopping-power and range prediction in particle therapy. Radiotherapy and Oncology. 2021 Oct;163:7–13.
JournalRadiotherapy and Oncology
- Dual-Energy Computed Tomography to Assess Intra- and Inter-Patient Tissue Variability for Proton Treatment Planning of Patients With Brain Tumor.
- Authors: Wohlfahrt P, Möhler C, Troost EGC, Greilich S, Richter C
- Issue date: 2019 Nov 1
- Inter-centre variability of CT-based stopping-power prediction in particle therapy: Survey-based evaluation.
- Authors: Taasti VT, Bäumer C, Dahlgren CV, Deisher AJ, Ellerbrock M, Free J, Gora J, Kozera A, Lomax AJ, De Marzi L, Molinelli S, Kevin Teo BK, Wohlfahrt P, Petersen JBB, Muren LP, Hansen DC, Richter C
- Issue date: 2018 Apr
- Pre-clinical evaluation of dual-layer spectral computed tomography-based stopping power prediction for particle therapy planning at the Heidelberg Ion Beam Therapy Center.
- Authors: Faller FK, Mein S, Ackermann B, Debus J, Stiller W, Mairani A
- Issue date: 2020 Apr 24
- Evaluation of Stopping-Power Prediction by Dual- and Single-Energy Computed Tomography in an Anthropomorphic Ground-Truth Phantom.
- Authors: Wohlfahrt P, Möhler C, Richter C, Greilich S
- Issue date: 2018 Jan 1
- Towards sub-percentage uncertainty proton stopping-power mapping via dual-energy CT: direct experimental validation and uncertainty analysis of a statistical iterative image reconstruction method.
- Authors: Medrano M, Liu R, Zhao T, Webb T, Politte DG, Whiting BR, Liao R, Ge T, Porras-Chaverri MA, O'Sullivan JA, Williamson JF
- Issue date: 2022 Jan 14